Group One Trading
TCRT icon

Group One Trading’s Alaunos Therapeutics TCRT Stock Holding History

Group One Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-300
Closed -$1.46K – 9131
2025
Q2 		$1.46K Hold
300
– – ﹤0.01% 7490
2025
Q1 		$435 Hold
300
– – ﹤0.01% 7299
2024
Q4 		$570 Sell
300
-158
-34% -$351 ﹤0.01% 6990
2024
Q3 		$1.51K Sell
458
-812
-64% -$2.92K ﹤0.01% 6213
2024
Q2 		$8.88K Sell
1,270
-74
-6% -$883 ﹤0.01% 5688
2024
Q1 		$24.3K Sell
1,344
-208
-13% -$4.16K ﹤0.01% 5279
2023
Q4 		$16.5K Hold
1,552
– – ﹤0.01% 5891
2023
Q3 		$30.7K Sell
1,552
-165
-10% -$7.11K ﹤0.01% 5524
2023
Q2 		$131K Buy
1,717
+675
+65% +$54.6K ﹤0.01% 4343
2023
Q1 		$98.5K Sell
1,042
-762
-42% -$72.6K ﹤0.01% 4318
2022
Q4 		$176K Sell
1,804
-1,144
-39% -$166K ﹤0.01% 3961
2022
Q3 		$761K Buy
2,948
+973
+49% +$283K ﹤0.01% 2840
2022
Q2 		$367K Buy
1,975
+207
+12% +$19.8K ﹤0.01% 3706
2022
Q1 		$173K Buy
1,768
+461
+35% +$59.2K ﹤0.01% 4953
2021
Q4 		$214K Buy
1,307
+431
+49% +$94.7K ﹤0.01% 5017
2021
Q3 		$239K Sell
876
-172
-16% -$52.6K ﹤0.01% 4984
2021
Q2 		$415K Buy
1,048
+716
+216% +$334K ﹤0.01% 4434
2021
Q1 		$179K Sell
332
-780
-70% -$486K ﹤0.01% 5137
2020
Q4 		$421K Buy
1,112
+854
+331% +$340K ﹤0.01% 3426
2020
Q3 		$98K Buy
258
+42
+19% +$18.6K ﹤0.01% 4208
2020
Q2 		$107K Sell
216
-36
-14% -$16.1K ﹤0.01% 3857
2020
Q1 		$92K Sell
252
-1,741
-87% -$901K ﹤0.01% 3363
2019
Q4 		$1.41M Sell
1,993
-410
-17% -$282K 0.01% 1576
2019
Q3 		$1.54M Buy
2,403
+430
+22% +$341K 0.01% 1406
2019
Q2 		$1.73M Buy
1,973
+765
+63% +$526K 0.02% 1188
2019
Q1 		$698K Sell
1,208
-1,235
-51% -$516K 0.01% 1686
2018
Q4 		$685K Buy
2,443
+159
+7% +$62.9K 0.01% 1783
2018
Q3 		$1.1M Sell
2,284
-114
-5% -$48.9K 0.01% 1635
2018
Q2 		$1.09M Buy
2,398
+1,159
+94% +$735K 0.01% 1650
2018
Q1 		$729K Sell
1,239
-463
-27% -$289K 0.01% 1748
2017
Q4 		$1.06M Sell
1,702
-491
-22% -$353K 0.01% 1656
2017
Q3 		$2.02M Buy
2,193
+947
+76% +$841K 0.02% 1041
2017
Q2 		$1.16M Buy
1,246
+851
+215% +$834K 0.01% 1333
2017
Q1 		$375K Sell
395
-2,182
-85% -$2.03M ﹤0.01% 2065
2016
Q4 		$2.07M Buy
2,577
+105
+4% +$94.6K 0.02% 899
2016
Q3 		$2.09M Sell
2,472
-860
-26% -$691K 0.02% 824
2016
Q2 		$2.74M Buy
3,332
+1,373
+70% +$1.49M 0.03% 643
2016
Q1 		$2.18M Sell
1,959
-441
-18% -$451K 0.03% 724
2015
Q4 		$2.99M Buy
2,400
+973
+68% +$1.61M 0.04% 622
2015
Q3 		$1.93M Sell
1,427
-1,331
-48% -$2.2M 0.03% 807
2015
Q2 		$4.96M Buy
+2,758
New +$4.28M 0.07% 331
2015
Q1 		– Sell
-2,115
Closed -$3.13M – 5165
2014
Q4 		$1.61M Sell
2,115
-784
-27% -$416K 0.02% 771
2014
Q3 		$1.15M Sell
2,899
-1,220
-30% -$588K 0.02% 1012
2014
Q2 		$2.49M Buy
4,119
+1,487
+56% +$828K 0.04% 578
2014
Q1 		$1.81M Buy
2,632
+25
+1% +$16.7K 0.03% 671
2013
Q4 		$1.7M Buy
2,607
+1,474
+130% +$878K 0.03% 737
2013
Q3 		$672K Sell
1,133
-451
-28% -$203K 0.01% 1339
2013
Q2 		$499K Buy
+1,584
New +$440K 0.01% 1363

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Group One Trading's TCRT Position: Q3 2025 in Review

Group One Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2025, closing a stake of 300 shares — an estimated $1.46K sold.

Group One Trading first reported a position in TCRT in Q2 2013 and held it in 48 quarters. The position peaked at $4.96M in Q2 2015. 26 funds tracked by Wall St. Rank hold TCRT as of Q3 2025.

  • Group One Trading reported no remaining Alaunos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 300 Alaunos Therapeutics shares in Q3 2025, an estimated $1.46K.
  • Group One Trading first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 48 quarters.
  • Group One Trading's Alaunos Therapeutics position peaked at $4.96M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.